33 — 6 (44) 2022 — Khakimov Sh.N., Soleeva S.Sh., FEATURES OF THE DEVELOPMENT OF CHRONIC HEART FAILURE IN DIABETIC NEPHROPATHY

FEATURES OF THE DEVELOPMENT OF CHRONIC HEART FAILURE IN DIABETIC NEPHROPATHY

Khakimov Sh.N., Samarkand state medical university

Soleeva S.Sh., Samarkand state medical university

Resume

The authors analyzed a scientific study on the study of diabetes mellitus (DM) and chronic heart failure (CHF) due to common pathophysiological processes that determine the prognosis and development of both diseases. According to the studied scientific data, it was stated that in recent years, due to the development of diabetes, the number of patients with its complications has increased, especially diabetic nephropathy, which is the most common complication of diabetes mellitus and increases the risk of fatal consequences. And the causes of death in more than 50% of cases are diseases of the cardiovascular system (sudden death syndrome – 80%, myocardial infarction – 13%). With the analyzed data, the authors set a goal in subsequent studies to study the development of CHF in diabetic nephropathy. The study revealed a relationship between the development of CHF in patients with type 2 diabetes mellitus complicated by diabetic nephropathy. The causes of death among the studied group of patients in more than 50% of cases are diseases of the cardiovascular system

Key words: diabetes mellitus, diabetic nephropathy, chronic heart failure, hemodialysis, left ventricular hypertrophy, arterial hypertension

First page

186

Last page

189

For citation: Khakimov Sh.N., Soleeva S.Sh., FEATURES OF THE DEVELOPMENT OF CHRONIC HEART FAILURE IN DIABETIC NEPHROPATHY //New Day in Medicine 6(44)2022 186-189 https://clck.bar/L16aec

LIST OF REFERENCES:

1. Ablakulova  M.Kh.,  Khusinova  Sh.A.,  Yuldosheva  N.E.  “The  prevalence  of  coronary  heart  disease  in  the urban unorganized population of the city of samarkand”  Journal of cardiorespiratory research. 2022, vol 3,  issue  1, pp. 23-25 http://dx.doi.org/10.5281/zenodo.6401043
2. Irina Agababyan, Sitora Soliyeva, Yulduz Ismoilova. (2021). Condition of Coronary Arteries and Change of Lipid Profile in Coronary Heart Disease. Annals of the Romanian Society for Cell Biology, 207–213. Retrieved from https://www.annalsofrscb.ro/index.php/journal/article/view/99
3. Irina Rubenovna Agababyan, Sitora Shahobovna Soleeva, Muyassar Gafurjanovna Mukhemedovа, Jamol Uzokov. Сondition of coronary arteries and change of lipid profile in coronary heart disease. //Journal of critical reviews 2020 August .р.4719-4723.
4. L.R. Khakimova, Sh.A. Yusupov, Sh.A. Khusinova, D. A. Shamsiev, Urolithiasis in Children (Literature Review), //American Journal of Medicine and Medical Sciences, Vol. 12 No. 1, 2022, pp. 18-25. doi: 10.5923/j.ajmms.20221201.04.
5. Piepoli M.F., Hoes A.W., Agewall S., et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016;37(29):2315-2381. DOI: 10.1093/eurheartj/ehw1069.
6. Ponikowski P., Voors A.A., Anker S.D., et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129-2200. DOI: 10.1093/eurheartj/ehw128Поступила в редакцию: 17.09.2021После доработки: 25.10.2021
7. Seferović P.M., Petrie M.C., Filippatos G.S., et al. Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology. //Eur J Heart Fail. 2018;20(5):853-872. DOI: 10.1002/ejhf.1170 Juvenis scientia 272021 | Том 7 | No 5www.jscientia.org11.
8. Soleeva S.Sh., Djabbarova N.M.,Muradov Sh.B. The state of diastolic dysfunction of tne left ventricle in patients with myocardial infarction. //Journal of cardiorespiratoryresearch. 2020, vol.3, issue 1, pp.78-81http://dx.doi.org/10.26739/2181-0974-2020-3-16
9. Valensi P., Meune C. Congestive heart failure caused by silent ischemia and silent myocardial infarction: Diagnostic challenge in type 2 diabetes. Kongestive Herzinsuffizienz durch stumme Ischämie und stummen Herzinfarkt: Diagnostische Herausforderung bei Typ-2-Diabetes. Herz. 2019;44(3):210-217. DOI: 10.1007/s00059-019-4798-38.
10. Агабабян И.Р., Солеева С.Ш. Артериальная гипертензия и связанная с ней коморбидность //Проблемы биологии и медицины. – 2020. №6. Том. 124. – С. 211-215. DOI: http://doi.org/10.38096/2181-5674.2020.6.00338
11. Агабабян И.Р., Солеева С.Ш. Место статинов в комплексном лечении SARS-COV-2. //Вопросы науки и образования №14 (139) 2021. с.70-80.
12. Рахимова Х.М., Сулайманова Н.Э. Назначение пробиотиков при детских функциональных желудочно-кишечных расстройствах  Босма шаклида  //Ж: Проблемы биологии и медицины, С., 2020г., №6 (124), стр.99-102
13. Холбаев С.Б., Юсупов. Ш.А., Юлдашова Н.Э., Сулайманова Н.Э. Влияние лечения ожирения медикаментозной терапией на клинические проявления остеоартроза коленных суставов на первичном звене здравоохранения.  // Научно-практический журнал. Достижения клинической и экспериментальной медицины, г. Тернополь (Украина), 2020г., №3, стр.181-186.